Equity (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Statement [LineItems] |
|
| Appropriations of Earnings and Dividends Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Resolution date of TSMC’s Board of Directors in its meeting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special capital reserve |
|
$ |
(6,287.0 |
) |
|
|
|
$ |
10,201.2 |
|
|
|
|
$ |
710.2 |
|
|
|
|
$ |
3,304.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends to shareholders |
|
$ |
71,308.5 |
|
|
|
|
$ |
71,308.5 |
|
|
|
|
$ |
71,308.5 |
|
|
|
|
$ |
71,308.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per share (NT$) |
|
$ |
2.75 |
|
|
|
|
$ |
2.75 |
|
|
|
|
$ |
2.75 |
|
|
|
|
$ |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Resolution date of TSMC’s Board of Directors in its meeting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special capital reserve |
|
$ |
(15,541.0 |
) |
|
|
|
$ |
(12,002.8 |
) |
|
|
|
$ |
(31,910.4 |
) |
|
|
|
$ |
17,166.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends to shareholders |
|
$ |
71,308.5 |
|
|
|
|
$ |
71,308.5 |
|
|
|
|
$ |
71,308.5 |
|
|
|
|
$ |
71,308.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per share (NT$) |
|
$ |
2.75 |
|
|
|
|
$ |
2.75 |
|
|
|
|
$ |
2.75 |
|
|
|
|
$ |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Resolution date of TSMC’s Board of Directors in its meeting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special capital reserve |
|
$ |
3,273.5 |
|
|
|
|
$ |
(6,365.5 |
) |
|
|
|
$ |
(17,228.4 |
) |
|
|
|
$ |
28,020.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends to shareholders |
|
$ |
77,796.2 |
|
|
|
|
$ |
77,796.2 |
|
|
|
|
$ |
90,762.3 |
|
|
|
|
$ |
90,762.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per share (NT$) |
|
$ |
3.00 |
|
|
|
|
$ |
3.00 |
|
|
|
|
$ |
3.50 |
|
|
|
|
$ |
3.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Changes in Other Reserves |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, 2021 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
$ |
(57,001.6 |
) |
|
|
|
$ |
2,321.8 |
|
|
|
|
$ |
- |
|
|
|
|
$ |
- |
|
|
|
|
$ |
(54,679.8 |
) |
Exchange differences arising on translation of foreign operations |
|
|
(6,181.7 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(6,181.7 |
) |
Unrealized gain (loss) on financial assets at FVTOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity instruments |
|
|
- |
|
|
|
|
|
1,898.2 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
1,898.2 |
|
Debt instruments |
|
|
- |
|
|
|
|
|
(3,339.9 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(3,339.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, 2021 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative unrealized gain (loss) of equity instruments transferred to retained earnings due to disposal |
|
$ |
- |
|
|
|
|
$ |
(187.7 |
) |
|
|
|
$ |
- |
|
|
|
|
$ |
- |
|
|
|
|
$ |
(187.7 |
) |
Cumulative unrealized gain (loss) of debt instruments transferred to profit or loss due to disposal |
|
|
- |
|
|
|
|
|
(93.2 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(93.2 |
) |
Loss allowance adjustments from debt instruments |
|
|
- |
|
|
|
|
|
1.3 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
1.3 |
|
Gain (loss) arising on changes in the fair value of hedging instruments and hedged item affects profit or loss |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
90.2 |
|
|
|
|
|
- |
|
|
|
|
|
90.2 |
|
Transferred to initial carrying amount of hedged items |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
48.5 |
|
|
|
|
|
- |
|
|
|
|
|
48.5 |
|
Share of other comprehensive income (loss) of associates |
|
|
(120.0 |
) |
|
|
|
|
30.0 |
|
|
|
|
|
(14.7 |
) |
|
|
|
|
- |
|
|
|
|
|
(104.7 |
) |
Income tax effect |
|
|
- |
|
|
|
|
|
(56.2 |
) |
|
|
|
|
(3.4 |
) |
|
|
|
|
- |
|
|
|
|
|
(59.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year |
|
$ |
(63,303.3 |
) |
|
|
|
$ |
574.3 |
|
|
|
|
$ |
120.6 |
|
|
|
|
$ |
- |
|
|
|
|
$ |
(62,608.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, 2022 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
$ |
(63,303.3 |
) |
|
|
|
$ |
574.3 |
|
|
|
|
$ |
120.6 |
|
|
|
|
$ |
- |
|
|
|
|
$ |
(62,608.4 |
) |
Exchange differences arising on translation of foreign operations |
|
|
51,009.7 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
51,009.7 |
|
Unrealized gain (loss) on financial assets at FVTOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity instruments |
|
|
- |
|
|
|
|
|
(263.3 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(263.3 |
) |
Debt instruments |
|
|
- |
|
|
|
|
|
(10,513.7 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(10,513.7 |
) |
Cumulative unrealized gain (loss) of equity instruments transferred to retained earnings due to disposal |
|
|
- |
|
|
|
|
|
(303.3 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(303.3 |
) |
Cumulative unrealized gain (loss) of debt instruments transferred to profit or loss due to disposal |
|
|
- |
|
|
|
|
|
410.1 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
410.1 |
|
Loss allowance adjustments from debt instruments |
|
|
- |
|
|
|
|
|
0.9 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
0.9 |
|
Gain (loss) arising on changes in the fair value of hedging instruments and hedged item affects profit or loss |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
1,329.2 |
|
|
|
|
|
- |
|
|
|
|
|
1,329.2 |
|
Transferred to initial carrying amount of hedged items |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(52.9 |
) |
|
|
|
|
- |
|
|
|
|
|
(52.9 |
) |
Issuance of shares |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(451.9 |
) |
|
|
|
|
(451.9 |
) |
Share-based payment expenses recognized |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
266.7 |
|
|
|
|
|
266.7 |
|
Share of other comprehensive income (loss) of associates |
|
|
550.3 |
|
|
|
|
|
38.6 |
|
|
|
|
|
76.4 |
|
|
|
|
|
- |
|
|
|
|
|
665.3 |
|
Income tax effect |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
6.0 |
|
|
|
|
|
- |
|
|
|
|
|
6.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year |
|
$ |
(11,743.3 |
) |
|
|
|
$ |
(10,056.4 |
) |
|
|
|
$ |
1,479.3 |
|
|
|
|
$ |
(185.2 |
) |
|
|
|
$ |
(20,505.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, 2023 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
$ |
(11,743.3 |
) |
|
|
|
$ |
(10,056.4 |
) |
|
|
|
$ |
1,479.3 |
|
|
|
|
$ |
(185.2 |
) |
|
|
|
$ |
(20,505.6 |
) |
Exchange differences arising on translation of foreign operations |
|
|
(14,255.6 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(14,255.6 |
) |
Gain (Loss) on hedging instruments designated as hedges of net investments in foreign operations |
|
|
618.2 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
618.2 |
|
Unrealized gain (loss) on financial assets at FVTOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity instruments |
|
|
- |
|
|
|
|
|
1,953.0 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
1,953.0 |
|
Debt instruments |
|
|
- |
|
|
|
|
|
3,639.8 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
3,639.8 |
|
Cumulative unrealized gain (loss) of equity instruments transferred to retained earnings due to disposal |
|
|
- |
|
|
|
|
|
(151.9 |
) |
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(151.9 |
) |
Cumulative unrealized gain (loss) of debt instruments transferred to profit or loss due to disposal |
|
|
- |
|
|
|
|
|
473.9 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
473.9 |
|
Loss allowance adjustments from debt instruments |
|
|
- |
|
|
|
|
|
9.5 |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
9.5 |
|
Gain (loss) arising on changes in the fair value of hedging instruments and hedged item affects profit or loss |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(34.8 |
) |
|
|
|
|
- |
|
|
|
|
|
(34.8 |
) |
Transferred to initial carrying amount of hedged items |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(45.2 |
) |
|
|
|
|
- |
|
|
|
|
|
(45.2 |
) |
Issuance of shares |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
(586.0 |
) |
|
|
|
|
(586.0 |
) |
Share-based payment expenses recognized |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
- |
|
|
|
|
|
477.7 |
|
|
|
|
|
477.7 |
|
Share of other comprehensive income (loss) of associates |
|
|
63.9 |
|
|
|
|
|
32.2 |
|
|
|
|
|
(3.4 |
) |
|
|
|
|
- |
|
|
|
|
|
92.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year |
|
$ |
(25,316.8 |
) |
|
|
|
$ |
(4,099.9 |
) |
|
|
|
$ |
1,395.9 |
|
|
|
|
$ |
(293.5 |
) |
|
|
|
$ |
(28,314.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock - Common Stock [member] |
|
| Statement [LineItems] |
|
| Summary of Capital Stock and Capital Surplus |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized shares (in millions) |
|
|
|
|
|
|
28,050.0 |
|
|
|
|
|
|
|
|
|
|
|
28,050.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized capital |
|
|
|
|
|
$ |
280,500.0 |
|
|
|
|
|
|
|
|
|
|
$ |
280,500.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued and paid shares (in millions) |
|
|
|
|
|
|
25,930.3 |
|
|
|
|
|
|
|
|
|
|
|
25,932.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued capital |
|
|
|
|
|
$ |
259,303.8 |
|
|
|
|
|
|
|
|
|
|
$ |
259,320.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Surplus [member] |
|
| Statement [LineItems] |
|
| Summary of Capital Stock and Capital Surplus |
The categories of uses and the sources of capital surplus based on regulations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
May be used to offset a deficit, distributed as cash dividends, or transferred to share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
|
|
|
|
|
$ 24,183.6 |
|
|
|
|
|
|
|
|
|
|
|
$ 24,406.8 |
|
|
|
|
|
From merger |
|
|
|
|
|
|
22,803.3 |
|
|
|
|
|
|
|
|
|
|
|
22,803.3 |
|
|
|
|
|
From convertible bonds |
|
|
|
|
|
|
8,892.4 |
|
|
|
|
|
|
|
|
|
|
|
8,892.4 |
|
|
|
|
|
From difference between the consideration received and the carrying amount of the subsidiaries’ net assets during actual disposal |
|
|
|
|
|
|
8,406.3 |
|
|
|
|
|
|
|
|
|
|
|
8,406.3 |
|
|
|
|
|
Donations - donated by shareholders |
|
|
|
|
|
|
11.3 |
|
|
|
|
|
|
|
|
|
|
|
11.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
May only be used to offset a deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From share of changes in equities of subsidiaries |
|
|
|
|
|
$ |
4,229.9 |
|
|
|
|
|
|
|
|
|
|
$ |
4,199.9 |
|
|
|
|
|
From share of changes in equities of associates |
|
|
|
|
|
|
311.8 |
|
|
|
|
|
|
|
|
|
|
|
302.4 |
|
|
|
|
|
Donations - unclaimed dividend |
|
|
|
|
|
|
53.7 |
|
|
|
|
|
|
|
|
|
|
|
70.1 |
|
|
|
|
|
|
|
|
|
|
|
|
May not be used for any purpose |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee restricted shares |
|
|
|
|
|
|
438.0 |
|
|
|
|
|
|
|
|
|
|
|
783.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
69,330.3 |
|
|
|
|
|
|
|
|
|
|
$ |
69,876.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|